• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在鸡胚绒毛尿囊膜(CAM)模型中,使用维替泊芬(Visudyne)进行光动力疗法诱导新生血管闭塞的视频监测。

Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model.

作者信息

Debefve E, Pegaz B, van den Bergh H, Wagnières G, Lange N, Ballini J-P

机构信息

Ecole Polytechnique Fédérale de Lausanne, EPFL-ENAC-LPAS, 1015, Lausanne, Switzerland.

出版信息

Angiogenesis. 2008;11(3):235-43. doi: 10.1007/s10456-008-9106-4. Epub 2008 Mar 7.

DOI:10.1007/s10456-008-9106-4
PMID:18324477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2494573/
Abstract

The aim of the present study was to monitor photodynamic angioocclusion with verteporfin in capillaries. Details of this process were recorded under a microscope in real-time using a high-sensitivity video camera. A procedure was developed based on intravenous (i.v.) injection of a light-activated drug, Visudyne, into the chorioallantoic membrane (CAM) of a 12-day-old chicken embryo. The effect of light activation was probed after 24 h by i.v. injection of a fluorescent dye (FITC dextran), and analysis of its fluorescence distribution. The angioocclusive effect was graded based on the size of the occluded vessels, and these results were compared with clinical observations. The time-resolved thrombus formation taking place in a fraction of the field of view was video recorded using a Peltier-cooled CCD camera. This vessel occlusion in the CAM model was reproducible and, in many ways, similar to that observed in the clinical use of verteporfin. The real-time video recording permitted the monitoring of platelet aggregation and revealed size-selective vascular closure as well as some degree of vasoconstriction. Platelets accumulated at intravascular junctions within seconds after verteporfin light activation, and capillaries were found to be closed 15 min later at the applied conditions. Larger-diameter vessels remained patent. Repetition of these data with a much more sensitive camera revealed occlusion of the treated area after 5 min with doses of verteporfin and light similar to those used clinically. Consequently, newly developed light-activated drugs can now be studied under clinically relevant conditions.

摘要

本研究的目的是监测维替泊芬在毛细血管中的光动力血管闭塞情况。使用高灵敏度摄像机在显微镜下实时记录该过程的细节。基于将光激活药物维速达尔静脉注射到12日龄鸡胚的尿囊膜中,开发了一种程序。24小时后,通过静脉注射荧光染料(异硫氰酸荧光素葡聚糖)并分析其荧光分布,来探究光激活的效果。根据闭塞血管的大小对血管闭塞效果进行分级,并将这些结果与临床观察结果进行比较。使用珀尔帖冷却的电荷耦合器件相机对视野的一部分中发生的时间分辨血栓形成进行视频记录。尿囊膜模型中的这种血管闭塞是可重复的,并且在许多方面与维替泊芬临床使用中观察到的情况相似。实时视频记录允许监测血小板聚集,并揭示了大小选择性血管闭合以及一定程度的血管收缩。维替泊芬光激活后数秒内血小板在血管内连接处聚集,在所应用的条件下,15分钟后发现毛细血管关闭。较大直径的血管保持通畅。使用灵敏度更高的相机重复这些数据显示,在使用与临床相似剂量的维替泊芬和光的情况下,5分钟后治疗区域出现闭塞。因此,现在可以在临床相关条件下研究新开发的光激活药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a1/2494573/33b4b3029331/10456_2008_9106_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a1/2494573/cdd3b14a96a1/10456_2008_9106_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a1/2494573/c7970b87bc83/10456_2008_9106_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a1/2494573/1a15b9c35c1a/10456_2008_9106_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a1/2494573/c332837d5e75/10456_2008_9106_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a1/2494573/3fd979a8e342/10456_2008_9106_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a1/2494573/33b4b3029331/10456_2008_9106_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a1/2494573/cdd3b14a96a1/10456_2008_9106_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a1/2494573/c7970b87bc83/10456_2008_9106_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a1/2494573/1a15b9c35c1a/10456_2008_9106_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a1/2494573/c332837d5e75/10456_2008_9106_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a1/2494573/3fd979a8e342/10456_2008_9106_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a1/2494573/33b4b3029331/10456_2008_9106_Fig6_HTML.jpg

相似文献

1
Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model.在鸡胚绒毛尿囊膜(CAM)模型中,使用维替泊芬(Visudyne)进行光动力疗法诱导新生血管闭塞的视频监测。
Angiogenesis. 2008;11(3):235-43. doi: 10.1007/s10456-008-9106-4. Epub 2008 Mar 7.
2
Photodynamic therapy of subfoveal recurrences after laser photocoagulation of extrafoveal choroidal neovascularization in pathologic myopia.病理性近视中黄斑中心凹外脉络膜新生血管激光光凝术后黄斑中心凹下复发的光动力疗法
Graefes Arch Clin Exp Ophthalmol. 2003 Jul;241(7):567-570. doi: 10.1007/s00417-003-0686-9. Epub 2003 Jun 18.
3
Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.肿瘤宿主微环境对大鼠前列腺肿瘤模型光动力治疗的影响。
Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):720-7.
4
Combination therapy using verteporfin and ranibizumab; optimizing the timing in the CAM model.联合应用维替泊芬和雷珠单抗治疗;优化 CAM 模型中的时机。
Photochem Photobiol. 2009 Nov-Dec;85(6):1400-8. doi: 10.1111/j.1751-1097.2009.00604.x.
5
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.维替泊芬光动力疗法治疗病理性近视性黄斑下脉络膜新生血管。一项随机临床试验的1年结果——VIP报告第1号
Ophthalmology. 2001 May;108(5):841-52. doi: 10.1016/s0161-6420(01)00544-9.
6
Photodynamic therapy of corneal neovascularization with verteporfin.用维替泊芬进行角膜新生血管的光动力疗法。
Cornea. 2003 Jul;22(5):485-8. doi: 10.1097/00003226-200307000-00018.
7
Simple, reliable and fast spectrofluorometric method for determination of plasma Verteporfin (Visudyne) levels during photodynamic therapy for choroidal neovascularization.用于在脉络膜新生血管光动力治疗期间测定血浆维替泊芬(维速达尔)水平的简单、可靠且快速的荧光分光光度法。
Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):925-30.
8
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.维替泊芬光动力疗法治疗年龄相关性黄斑变性的中心凹下脉络膜新生血管:两项随机临床试验的一年结果——TAP报告。年龄相关性黄斑变性光动力疗法(TAP)研究组
Arch Ophthalmol. 1999 Oct;117(10):1329-45.
9
Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration.利用双光子激发光动力疗法实现鸡胚绒毛尿囊膜中血管的完全闭塞:对湿性年龄相关性黄斑变性治疗的启示
J Biomed Opt. 2007 May-Jun;12(3):034025. doi: 10.1117/1.2750663.
10
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.维替泊芬治疗年龄相关性黄斑变性中心凹下脉络膜新生血管:一项随机临床试验的两年结果,该试验纳入隐匿性无典型脉络膜新生血管病变——维替泊芬光动力疗法报告2
Am J Ophthalmol. 2001 May;131(5):541-60. doi: 10.1016/s0002-9394(01)00967-9.

引用本文的文献

1
Biomimetic Tumour Model Systems for Pancreatic Ductal Adenocarcinoma in Relation to Photodynamic Therapy.用于胰腺导管腺癌光动力治疗的仿生肿瘤模型系统
Int J Mol Sci. 2025 Jul 2;26(13):6388. doi: 10.3390/ijms26136388.
2
Phototherapy in cancer treatment: strategies and challenges.癌症治疗中的光疗:策略与挑战。
Signal Transduct Target Ther. 2025 Apr 2;10(1):115. doi: 10.1038/s41392-025-02140-y.
3
Spatially fractionated minibeam radiation delivered at clinically feasible dose rates induces transient vascular permeability.

本文引用的文献

1
Self-reported acute decrease in visual acuity after photodynamic therapy for age-related macular degeneration.年龄相关性黄斑变性光动力治疗后自我报告的视力急性下降
Retina. 2006 Nov-Dec;26(9):1042-8. doi: 10.1097/01.iae.0000254894.94013.d8.
2
Emerging drugs for age-related macular degeneration.用于年龄相关性黄斑变性的新型药物。
Expert Opin Emerg Drugs. 2006 Nov;11(4):725-40. doi: 10.1517/14728214.11.4.725.
3
Ranibizumab for neovascular age-related macular degeneration.雷珠单抗用于治疗新生血管性年龄相关性黄斑变性。
以临床可行的剂量率进行的空间分割微束辐射会诱导短暂的血管通透性。
Sci Rep. 2025 Mar 10;15(1):8210. doi: 10.1038/s41598-025-87395-9.
4
Verteporfin Photodynamic Therapy for the Treatment of Chorioretinal Conditions: A Narrative Review.维替泊芬光动力疗法治疗脉络膜视网膜疾病:一项叙述性综述
Clin Ophthalmol. 2024 Jun 10;18:1701-1716. doi: 10.2147/OPTH.S464371. eCollection 2024.
5
Efficient Assessment of Tumor Vascular Shutdown by Photodynamic Therapy on Orthotopic Pancreatic Cancer Using High-Speed Wide-Field Waterproof Galvanometer Scanner Photoacoustic Microscopy.使用高速宽场防水振镜扫描光声显微镜对原位胰腺癌的光动力治疗进行肿瘤血管关闭的有效评估。
Int J Mol Sci. 2024 Mar 19;25(6):3457. doi: 10.3390/ijms25063457.
6
Imaging and Histopathological Analysis of Microvascular Angiogenesis in Photodynamic Therapy for Oral Cancer.口腔癌光动力治疗中微血管生成的影像学与组织病理学分析
Cancers (Basel). 2023 Feb 9;15(4):1110. doi: 10.3390/cancers15041110.
7
Ru(II) CONTAINING PHOTOSENSITIZERS FOR PHOTODYNAMIC THERAPY: A CRITIQUE ON REPORTING AND AN ATTEMPT TO COMPARE EFFICACY.用于光动力疗法的含钌(II)光敏剂:关于报告的评论及疗效比较尝试
Coord Chem Rev. 2022 Nov 1;470. doi: 10.1016/j.ccr.2022.214712. Epub 2022 Jul 26.
8
The Chicken Embryo Chorioallantoic Membrane as an In Vivo Model for Photodynamic Therapy.鸡胚尿囊膜作为活体光动力疗法模型。
Methods Mol Biol. 2022;2451:107-125. doi: 10.1007/978-1-0716-2099-1_9.
9
Vascular Shutdown by Photodynamic Therapy Using Talaporfin Sodium.使用替拉泊芬钠通过光动力疗法实现血管闭塞
Cancers (Basel). 2020 Aug 21;12(9):2369. doi: 10.3390/cancers12092369.
10
Ring-Fused Diphenylchlorins as Potent Photosensitizers for Photodynamic Therapy Applications: In Vitro Tumor Cell Biology and in Vivo Chick Embryo Chorioallantoic Membrane Studies.稠环二苯基二氢卟酚作为用于光动力治疗的强效光敏剂:体外肿瘤细胞生物学及体内鸡胚绒毛尿囊膜研究
ACS Omega. 2019 Oct 9;4(17):17244-17250. doi: 10.1021/acsomega.9b01865. eCollection 2019 Oct 22.
N Engl J Med. 2006 Oct 5;355(14):1419-31. doi: 10.1056/NEJMoa054481.
4
Effect of nanoparticle size on the extravasation and the photothrombic activity of meso(p-tetracarboxyphenyl)porphyrin.纳米颗粒大小对中位(对四羧基苯基)卟啉的渗出及光血栓形成活性的影响。
J Photochem Photobiol B. 2006 Dec 1;85(3):216-22. doi: 10.1016/j.jphotobiol.2006.07.008. Epub 2006 Sep 18.
5
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension: TAP report no. 8.维替泊芬治疗年龄相关性黄斑变性中心凹下脉络膜新生血管:两项随机临床试验及开放标签扩展研究的5年结果:TAP报告第8号
Graefes Arch Clin Exp Ophthalmol. 2006 Sep;244(9):1132-42. doi: 10.1007/s00417-005-0199-9. Epub 2006 Mar 15.
6
Photothrombic activity of m-THPC-loaded liposomal formulations: pre-clinical assessment on chick chorioallantoic membrane model.载有间-四(对磺基苯)卟啉的脂质体制剂的光血栓形成活性:鸡胚绒毛尿囊膜模型的临床前评估
Eur J Pharm Sci. 2006 May;28(1-2):134-40. doi: 10.1016/j.ejps.2006.01.008. Epub 2006 Feb 28.
7
Encapsulation of porphyrins and chlorins in biodegradable nanoparticles: the effect of dye lipophilicity on the extravasation and the photothrombic activity. A comparative study.卟啉和二氢卟吩在可生物降解纳米颗粒中的封装:染料亲脂性对血管外渗和光血栓形成活性的影响。一项比较研究。
J Photochem Photobiol B. 2005 Jul 1;80(1):19-27. doi: 10.1016/j.jphotobiol.2005.02.003. Epub 2005 Apr 9.
8
Preclinical evaluation of a novel water-soluble chlorin E6 derivative (BLC 1010) as photosensitizer for the closure of the neovessels.一种新型水溶性二氢卟吩E6衍生物(BLC 1010)作为用于封闭新生血管的光敏剂的临床前评估。
Photochem Photobiol. 2005 Nov-Dec;81(6):1505-10. doi: 10.1562/2005-02-23-RA-448.
9
Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos.负载于纳米颗粒中的卟啉光动力活性增强:利用鸡胚进行的体内评估
Int J Pharm. 2004 Nov 22;286(1-2):131-45. doi: 10.1016/j.ijpharm.2004.07.029.
10
Contrast sensitivity as an outcome measure in patients with subfoveal choroidal neovascularisation due to age-related macular degeneration.对比敏感度作为年龄相关性黄斑变性所致黄斑中心凹下脉络膜新生血管患者的一项预后指标。
Eye (Lond). 2005 Nov;19(11):1142-50. doi: 10.1038/sj.eye.6701717.